Micro Therapeutics Inc.

The Irvine maker of medical devices for the diagnosis and treatment of vascular disease reported a net loss of $2.6 million, or 30 cents a share, for the first three months this year, compared with last year’s first-quarter loss of $3.5 million, or 52 cents a share. Quarterly sales grew to $1.1 million from $812,753 last year.